Seasoned investor and operating executive focused on growth-stage technology and financial services businesses. Michael Alfred combines operational leadership with transaction experience across growth equity, M&A and strategic finance, often working with founder-led teams to scale revenue and margins. Prior roles span corporate strategy, buyout and portfolio company management; holds degrees in business and finance.
Seasoned investor and operating executive focused on growth-stage technology and financial services businesses. Michael Alfred combines operational leadership with transaction experience across growth equity, M&A and strategic finance, often working with founder-led teams to scale revenue and margins. Prior roles span corporate strategy, buyout and portfolio company management; holds degrees in business and finance.
Combines operational rigor with growth-equity discipline to back founder-led technology and financial-services companies. Prefers revenue-stage opportunities where strategic capital, M&A experience and hands-on operating support can accelerate scale and margin expansion. Allocates capital with concentrated, conviction-weighted positions and structured governance to protect downside while funding aggressive top-line investments. Maintains a 3–7 year horizon for value realization, prioritizes repeatable unit economics, customer retention, and capital-efficient growth, and emphasizes measurable KPIs, scenario-based stress testing, and collaborative governance.
Combines operational rigor with growth-equity discipline to back founder-led technology and financial-services companies. Prefers revenue-stage opportunities where strategic capital, M&A experience and hands-on operating support can accelerate scale and margin expansion. Allocates capital with concentrated, conviction-weighted positions and structured governance to protect downside while funding aggressive top-line investments. Maintains a 3–7 year horizon for value realization, prioritizes repeatable unit economics, customer retention, and capital-efficient growth, and emphasizes measurable KPIs, scenario-based stress testing, and collaborative governance.
| Trades 53 | Longs Won 26/53 49% | Profit Factor 0.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.65M |
| Average Win $892,535.3 | Best Trade (Oct 22) $10.81M | Sharpe Ratio -11.39 |
| Average Loss -$1.98M | Worst Trade (Oct 22) -$16.31M | Z-Score -2.22 (100%) |
| Commissions $0 | Avg. Trade Length 6m 1w | Expectancy -$568,877.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 50 | 45 | 40 | 35 | 30 | 25 | 20 | 15 | 10 | 5 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ASST Strive, Inc. Class A Common Stock | 560,000 | $5.61M | $16.33M | - | $10.72M | 191.02% | +0.448% |
BBBY Neighborhood Intelligence, Inc. | 100,000 | $579,000 | $148,000 | - | -$431,000 | -74.44% | +5.714% |
BKKT Bakkt Holdings, Inc. Class A Common Stock | 905,000 | $8.51M | $4.57M | - | -$3.93M | -46.23% | -3.531% |
BMNR BitMine Immersion Technologies, Inc. | 100,000 | $1.93M | $2.24M | - | $316,760 | 16.44% | -0.311% |
CELH Celsius Holdings Inc. | 10,000 | $292,800 | $285,550 | - | -$7,250 | -2.48% | +0.688% |
CIFR Cipher Digital Inc. | 3.37M | $42.45M | $27.11M | - | -$15.34M | -36.14% | -3.365% |
CP Canadian Pacific Kansas City Ltd. | 2,000 | $147,260 | $179,860 | - | $32,600 | 22.14% | -0.761% |
ENHA Enhanced Group Inc. Class A Common Stock | 36,000 | $103,320 | $40,140 | - | -$63,180 | -61.15% | -1.327% |
ETHA iShares Ethereum Trust ETF | 186,480 | $10.07M | $10.11M | - | $39,706.25 | 0.39% | +0.631% |
IREN IREN Ltd. | 750,461 | $35.22M | $19.08M | - | -$16.14M | -45.82% | -0.333% |
NVO Novo Nordisk A/S Sponsored ADR | 201,000 | $10.19M | $7.82M | - | -$2.37M | -23.24% | -1.306% |
OPEN Opendoor Technologies Inc. | 4.74M | $20.96M | $9.47M | - | -$11.49M | -54.82% | -0.99% |
PEP PepsiCo, Inc. | 1,000 | $143,520 | $135,560 | - | -$7,960 | -5.55% | -2.355% |
REGN Regeneron Pharmaceuticals, Inc. | 500 | $281,135 | $403,318.1 | - | $122,183.1 | 43.46% | -1.52% |
SLNH Soluna Holdings, Inc. Common Stock | 750,882 | $1.21M | $425,524.83 | - | -$783,395.19 | -64.8% | +6.925% |
STZ Constellation Brands Inc. Class A | 1,000 | $137,960 | $138,110 | - | $150 | 0.11% | -0.626% |
TGT Target Corp. | 1,000 | $97,750 | $152,080 | - | $54,330 | 55.58% | -3.814% |
WYNN Wynn Resorts, Limited | 5,000 | $485,450 | $363,279.5 | - | -$122,170.5 | -25.17% | -3.293% |